( ection 29. ...)Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting,Health

ection 29. Abstract # 725 ----------------------------------- ------------- Experimental and Molecular Poster in Therapeutics 4 Exhibit Hall Board 4- Poster Section 21. Abstract # 509 --------- ----------------------------------- ------------- 1pm-5pm Experimental and Molecular Poster in Therapeutics Exhibit Hall Poster Section 9 Abstract # 983 ----------------------------------- ------------- Experimental and Molecular Poster in Therapeutics 9 Exhibit Hall Poster Section 28 Abstract # 1452 ---------- --------- ----------------------------------- ------------- Tuesday 3:30pm High Impact Late-Breaking Research Oral April 17 1 Presentation in Hall A Abstract #
'"/>




Page: 1 2 3 4 5 6
Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care